Share on StockTwits

Receptos (NASDAQ:RCPT) posted its quarterly earnings results on Tuesday. The company reported ($1.04) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.85) by $0.19, American Banking and Market News reports. The company had revenue of $1.10 million for the quarter, compared to the consensus estimate of $1.28 million.

Shares of Receptos (NASDAQ:RCPT) opened at 44.46 on Tuesday. Receptos has a one year low of $15.21 and a one year high of $55.00. The stock has a 50-day moving average of $39.94 and a 200-day moving average of $39.12. The company’s market cap is $985.6 million.

Several analysts have recently commented on the stock. Analysts at Nomura initiated coverage on shares of Receptos in a research note on Monday, June 30th. They set a “buy” rating and a $63.00 price target on the stock. On the ratings front, analysts at BMO Capital Markets set a $58.00 price target on shares of Receptos in a research note on Tuesday, June 10th. Finally, analysts at Wedbush raised their price target on shares of Receptos to $63.00 in a research note on Tuesday, June 10th. Three investment analysts have rated the stock with a buy rating, The stock presently has a consensus rating of “Buy” and a consensus price target of $58.00.

Receptos, Inc (NASDAQ:RCPT) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.